Description
Up to 50% of American women and 30% of American men will suffer with a fracture related to weakened bone some time in their life. Osteoporosis is often called a “silent disease” as you cannot feel your bones getting weaker. Now we can assess the risk earlier with testing specific gene variants, including Vitamin D.
Ideal Candidates for this panel are individuals with the following conditions:
Diagnosed with osteoporosis or osteopenia
Conditions that prevent proper vitamin D absorption
Individuals with compromised mobility
People in low sun exposure areas
Menopausal changes
History of a minimal-trauma fracture
Low blood calcium (hypocalcemia)
Low blood phosphate (hypophosphatemia)
Technology Matters
Our partners at Kashi Clinical Laboratories use the latest in quantitative real-time polymerase chain reaction instrumentation with a high degree of sensitivity for detecting gene snips accurately.
Scientific rigor matters
SNP’s are only included in our panels when peer reviewed studies show there is a clear connection with treatment decision making, the studies are relevant across a range of population types, clinical intervention is indicated, and that nutritional or other lifestyle choices can affect the regulation of gene expression.
Results and Resources
Your results will be ready within 5-7 business days of receipt at the lab. Once your results are ready, an InVite® certified healthcare professional will contact you to discuss your results and recommend a supplement protocol based on your specific results.
The programs listed below are recommendations from InVite® Experts and have been developed based on the individual gene mutations that may show up on your test results. Once your results are ready, an InVite® Expert will guide you through the best program for your needs.